Cytomel (Liothyronine) Cost in Missouri 2026

What Liothyronine Is and Why Missouri Patients Use It

Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone. It carries FDA approval for hypothyroidism, thyroid suppression therapy, and as a diagnostic agent in thyroid suppression tests. [1] Most prescriptions in Missouri are written as an adjunct to levothyroxine (T4) for patients whose symptoms persist despite normal TSH levels on T4 monotherapy.

The clinical rationale dates to a 1999 NEJM trial by Bunevicius et al. (N=33) showing that partial substitution of levothyroxine with liothyronine improved mood and neuropsychological function versus T4 alone. [2] That trial remains frequently cited even though larger confirmatory data are mixed, and the American Thyroid Association's 2014 guidelines acknowledge ongoing debate about combination therapy. [3]

Liothyronine has a short half-life of roughly 1 day, much shorter than levothyroxine's 6 to 7 day half-life, which means blood T3 levels fluctuate more between doses. [4] Twice-daily dosing is often preferred for that reason. Starting doses typically range from 5 to 25 mcg daily, with most maintenance doses landing between 25 to 75 mcg/day depending on residual thyroid function and concurrent levothyroxine use. [1]

Missouri saw a noticeable uptick in T3-related telehealth prescriptions between 2022 and 2024, driven partly by direct-to-patient thyroid optimization platforms. That pattern mirrors national trends documented in FDA MedWatch reports and pharmacy dispensing surveys. [5]

Exact Liothyronine Prices in Missouri for 2026

Brand Cytomel and generic liothyronine carry very different price tags. Knowing the specific numbers prevents overpaying by hundreds of dollars per year.

The Pfizer Wholesale Acquisition Cost (WAC) for brand Cytomel sits near $120 per month for a standard 25 mcg dose taken twice daily. That figure is the manufacturer list price before any pharmacy markup, insurance negotiation, or discount card. [6] Almost no Missouri cash-pay patient should pay WAC.

Generic liothyronine is manufactured by several companies including Mylan (now Viatris), Lannett, and Westminster Pharmaceuticals. [1] At Missouri retail chains like CVS, Walgreens, Walmart, and Schnucks, the 30-tablet cash price for 25 mcg generic tablets lands between $25 and $50 per month in 2026 depending on the specific store and whether a GoodRx, RxSaver, or NeedyMeds coupon is applied. The average cash-pay price across Missouri retail pharmacies in 2026 is approximately $35 per month with a discount program applied.

Compounded liothyronine from a licensed Missouri 503A pharmacy, discussed in detail below, runs approximately $40 per month for a custom-dose formulation, which is slightly higher than generic tablets but offers flexibility in dose increments not available commercially. [7]

Missouri 2026 Liothyronine Price Comparison

| Source | Monthly Cost (est.) | Notes | |---|---|---| | Brand Cytomel (Pfizer WAC) | ~$120 | List price; rarely paid out-of-pocket | | Generic (no coupon, retail) | $50, $90 | Varies by pharmacy | | Generic + GoodRx/RxSaver | ~$25, $40 | Most common cash-pay scenario | | Compounded 503A (Missouri) | ~$40 | Custom dose; Rx required | | Missouri Medicaid | Not covered | Hypothyroidism indication excluded |

Walmart's $4/$10 generic list includes some thyroid drugs, but liothyronine is not consistently on that list at Missouri locations as of 2026. Always verify at the pharmacy counter before assuming program eligibility. [8]

Missouri Medicaid Coverage for Liothyronine

Missouri Medicaid does not cover liothyronine for hypothyroidism as of 2026. This is one of the more common coverage surprises Missouri patients encounter.

The Missouri HealthNet (MO Medicaid) Preferred Drug List (PDL) restricts liothyronine coverage primarily to type 2 diabetes-related thyroid conditions, not standard primary or secondary hypothyroidism. [9] Patients seeking T3 supplementation for symptom management after thyroid ablation, Hashimoto's thyroiditis, or persistent post-thyroidectomy symptoms will find no Medicaid reimbursement pathway without a prior authorization that demonstrates medical necessity outside the PDL indications, and those approvals are rarely granted for hypothyroidism adjunct use.

The Endocrine Society's 2019 clinical practice guideline on hypothyroidism states: "We recommend against the routine use of combination T4 and T3 therapy in hypothyroid patients," while acknowledging that individual patient response may justify a trial in selected cases. [10] That guideline language gives Medicaid medical directors a basis for denial.

Patients on Missouri Medicaid who need T3 coverage have two realistic options: a documented prior authorization with clinical evidence of T4 monotherapy failure, or purchasing generic liothyronine at the ~$35/month cash price out of pocket. For many Medicaid patients, the cash-pay route is more practical than the prior authorization process.

Dual-eligible Missouri patients (Medicare and Medicaid) may find Part D formulary coverage more accessible. Part D plans vary, but several 2026 Missouri Part D formularies include generic liothyronine at Tier 1 or Tier 2 with copays of $0, $10 per month. [11] Checking the Medicare Plan Finder tool at medicare.gov before each October 15 open enrollment period identifies the lowest-cost Part D option for a specific liothyronine dose.

Private Insurance Coverage for Cytomel in Missouri

Most commercial insurance plans in Missouri cover generic liothyronine; fewer cover brand Cytomel without a step-therapy or prior authorization requirement.

Missouri's major insurers, Anthem BlueCross BlueShield, Cigna, United Healthcare, and Aetna, all maintain drug formularies that tier liothyronine differently from plan to plan. Generic liothyronine typically lands at Tier 1 or Tier 2, meaning copays of $5, $30 per month for most commercial members. [12] Brand Cytomel frequently sits at Tier 3 or higher, where cost-sharing can reach $60, $100 per month even with insurance.

Step therapy is common. Many Missouri commercial plans require a trial of levothyroxine (T4 monotherapy) before approving liothyronine coverage. The standard step-therapy requirement is a 90-day T4 trial with documented ongoing symptoms and a TSH within the reference range. [13] Prescribers can submit a step-therapy exception request if clinical circumstances warrant it, for example, a patient with documented T4-to-T3 conversion impairment due to a DIO2 polymorphism.

The Pfizer Cytomel Savings Card, available through the Pfizer brand website, can reduce brand Cytomel cost to as low as $0, $30 per month for commercially insured patients who meet eligibility criteria. [14] The card does not apply to Medicaid, Medicare, or other government-funded plans. Missouri patients with commercial insurance who prefer brand Cytomel over generic should check eligibility at the Pfizer patient assistance portal before filling the first prescription.

Prior authorization timelines at Missouri insurers typically run 3, 7 business days for standard requests. Urgent PA requests, available when a patient is acutely hypothyroid post-thyroidectomy, can be processed in 24 to 72 hours. [12]

Is Compounded Liothyronine Legal in Missouri?

Yes. Compounded liothyronine T3 is legal in Missouri when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. [15]

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed compounding pharmacies to prepare individualized drug preparations for specific patients when a licensed prescriber issues a valid prescription. Missouri has its own Board of Pharmacy regulations that mirror federal 503A standards. [16] Compounded liothyronine is not manufactured in bulk for resale, each preparation must be patient-specific.

Why would a patient choose compounded liothyronine over a commercial generic that costs less? The main clinical reason is dose customization. Commercial tablets are available in 5 mcg, 25 mcg, and 50 mcg strengths. Some patients need 10 mcg, 15 mcg, or 37.5 mcg doses that are not commercially available. A 503A pharmacy can prepare those doses as tablets or capsules, sometimes in sustained-release formulations. [17]

The FDA has not approved any sustained-release liothyronine product, and the American Thyroid Association has raised concerns about pharmacokinetic variability in compounded slow-release T3 formulations. [3] Patients choosing compounded liothyronine should discuss the evidence gap with their prescriber. The Endocrine Society notes that "the bioavailability and clinical effects of compounded thyroid preparations have not been adequately studied in controlled trials." [10]

Missouri 503A pharmacies offering compounded liothyronine include compounding-focused independents in Kansas City, St. Louis, Springfield, and Columbia. The Missouri Board of Pharmacy maintains a licensee lookup at pr.mo.gov where patients can verify a pharmacy's compounding license before filling. [16]

503B outsourcing facilities (which supply hospitals and clinics in bulk) cannot legally dispense directly to individual Missouri patients without a patient-specific prescription routed through a licensed pharmacy. [15]

Telehealth Prescribing of Liothyronine in Missouri

Missouri law permits telehealth prescribing of liothyronine. A prescriber licensed in Missouri may issue a liothyronine prescription following a synchronous audio-video visit, provided the standard of care for thyroid evaluation is met. [18]

That standard of care includes a documented history, a recent TSH and free T4 result, and ideally a free T3 level if combination therapy is being considered. The American Association of Clinical Endocrinology (AACE) recommends measuring both TSH and free T4 when evaluating thyroid function, and adding free T3 when T3 therapy is planned. [19] Missouri telehealth prescribers are expected to follow the same diagnostic standard as in-person clinicians.

Missouri passed SB 681 in 2018, establishing a telehealth framework that allows prescribing after an appropriate patient-provider relationship is established via synchronous video technology. Telephone-only (audio-only) visits may not meet the Missouri standard for initiating a new controlled or specialty prescription, though liothyronine is not a scheduled controlled substance. [18]

HealthRX offers Missouri patients synchronous video visits with clinicians who can evaluate thyroid labs, review symptom burden, and prescribe liothyronine where clinically appropriate. After the visit, the prescription goes electronically to the patient's preferred Missouri pharmacy or a compounding pharmacy of the patient's choice.

Post-COVID federal flexibilities that had expanded telephone-only prescribing have largely expired for non-controlled substances in Missouri as of 2025. Patients should confirm their telehealth platform uses video, not telephone only, before the visit. [18]

Strategies to Minimize Liothyronine Cost in Missouri

Several concrete steps reduce out-of-pocket liothyronine costs for Missouri patients in 2026.

Step 1: Use a discount card at the pharmacy. GoodRx, RxSaver, NeedyMeds, and Blink Health all negotiate below-WAC prices at Missouri retail pharmacies. These cards are free and do not require insurance. Prices vary by zip code; Kansas City and St. Louis metro pharmacies often show lower card prices than rural Missouri locations. [20]

Step 2: Ask for 90-day supply. Most Missouri retail pharmacies and mail-order services offer a per-unit discount on 90-day fills versus 30-day fills. At a per-tablet cost of roughly $0.50, $1.20 for generic liothyronine, a 90-day supply of 25 mcg twice daily (180 tablets) typically costs $18, $45 out of pocket with a discount card. [8]

Step 3: Check the Pfizer patient assistance program. The Pfizer RxPathways program provides free or reduced-cost brand Cytomel to uninsured or underinsured patients who meet income eligibility thresholds (generally at or below 400% of the federal poverty level). [14] Missouri patients can apply at pfizer.com/rxpathways.

Step 4: Compare Part D formularies annually. Missouri Part D plan formularies change each January 1. A plan that covered liothyronine at Tier 1 in 2025 may move it to Tier 2 in 2026. The Medicare Plan Finder tool at medicare.gov allows exact drug-level formulary comparison before enrolling. [11]

Step 5: Consider telehealth for the initial prescription. Telehealth visits for thyroid evaluation often cost $75, $150 per visit without insurance, compared to $200, $400 for an in-person endocrinology consultation in Missouri. For patients paying cash, the lower visit cost preserves funds for the medication itself.

Step 6: Verify compounding necessity before paying more. Compounded liothyronine at ~$40/month costs slightly more than the generic cash-pay price of ~$35/month. Only choose compounded T3 if a clinically necessary dose or formulation is unavailable commercially.

Clinical Pharmacology: What Missouri Patients and Prescribers Need to Know

Liothyronine binds thyroid hormone receptors directly as T3, without requiring hepatic or peripheral conversion from T4. This makes it useful in patients with reduced type 2 deiodinase (DIO2) activity, a condition linked to the rs225014 polymorphism, which affects approximately 12 to 16% of the population. [21]

Absorption after oral administration averages 95% (compared to 70 to 80% for levothyroxine), and peak serum T3 occurs within 2 to 4 hours of ingestion. [4] The short half-life of approximately 24 hours means that a missed dose produces a more rapid drop in circulating T3 than a missed levothyroxine dose. Patients should take liothyronine at the same time each day.

Drug interactions are clinically meaningful. Calcium carbonate, ferrous sulfate, and cholestyramine each reduce liothyronine absorption when taken within 4 hours of the dose. [1] Amiodarone inhibits T4-to-T3 conversion and may alter the dose requirement for liothyronine in patients taking both medications. [22] Warfarin anticoagulation is potentiated by liothyronine; INR monitoring should increase when starting or adjusting T3 therapy. [23]

Cardiovascular safety data deserve attention. A 2019 observational cohort study published in JAMA Internal Medicine (N=162,369 thyroid patients) found no significant increase in atrial fibrillation risk with combination T4/T3 therapy versus T4 alone when TSH was maintained within reference range, but supraphysiologic T3 levels were associated with a 1.3-fold increase in AF risk. [24] Missouri prescribers typically check TSH, free T4, and free T3 approximately 6 weeks after any dose adjustment. [19]

Monitoring Parameters and Follow-Up Costs in Missouri

Starting liothyronine requires baseline and follow-up lab work. In Missouri, standard thyroid panels ordered through reference labs cost:

A TSH-only draw at Quest or LabCorp in Missouri runs $20, $40 without insurance. A comprehensive thyroid panel (TSH, free T4, free T3, anti-TPO antibodies) costs $80, $140 cash pay. [25] Many Missouri hospital labs and independent draw centers offer thyroid panels for less with online ordering through services like Ulta Lab Tests or Walk-In Lab.

The AACE recommends rechecking TSH and free T3 four to six weeks after initiating or changing liothyronine dose, then every six months once stable. [19] Over a year, that monitoring schedule adds approximately $80, $200 in lab costs for a cash-pay patient.

Telehealth prescribers using HealthRX coordinate lab orders through national reference lab networks, allowing Missouri patients to get blood drawn at a location within 20 miles of most Missouri zip codes. Results are reviewed asynchronously and sent to the patient within 48 hours.